Market Overview

UPDATE: Deutsche Bank Initiates Coverage on CVS Caremark on Industry Overhang Concerns

Share:
Related CVS
JP Morgan Downgrades Omnicare Following CVS Deal
Oppenheimer's 10 'Best Of The Best' Technical Buy Ideas
Rite Aid Rises On 'Positive' July Sales; CVS And Walgreens? (Investor's Business Daily)

In a report published Thursday, Deutsche Bank analyst George Hill initiated coverage on CVS Caremark Corporation (NYSE: CVS) with a Hold rating and $71.00 price target.

In the report, Deutsche Bank noted, “We are initiating coverage of CVS Caremark (CVS) with a Hold rating. CVS is a combination of one of the largest retail pharmacies and one of the largest PBMs in the United States. At the current share price, we fear industry overhangs related to the PBM could begin to weigh more heavily on the company's multiple, and at its current size, it is difficult to envision a catalyst that moves the needle to drive faster earnings growth or multiple expansion. Even a global generics purchasing deal, by our math, barely moves the needle for CVS.”

CVS Caremark closed on Wednesday at $65.42.

Latest Ratings for CVS

DateFirmActionFromTo
Jun 2015OppenheimerInitiates Coverage onOutperform
Jun 2015Cowen & CompanyMaintainsOutperform
Jun 2015MacquarieInitiates Coverage onOutperform

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: Deutsche Bank George HillAnalyst Color Initiation Analyst Ratings

 

Related Articles (CVS)

Get Benzinga's Newsletters